Sailing Across Contraception, Pregnancy, and Breastfeeding: The Complex Journey of Women with Cardiomyopathies

Maria Cristina Carella1,2, Vincenzo Ezio Santobuono1, Francesca Maria Grosso2,3

  • 1Cardiology Unit, Department of Interdisciplinary Medicine (DIM), University of Bari "Aldo Moro", University Hospital Consortium Polyclinic of Bari, 70124 Bari, Italy.

PubMed

Insights

Cardiomyopathy in women presents unique reproductive challenges. This review guides safe contraception, pregnancy, and breastfeeding for women with cardiomyopathy, emphasizing personalized care.

Area of Science:

  • Cardiology
  • Reproductive Medicine
  • Women's Health

Background:

  • Gender-specific cardiology highlights the need for tailored cardiovascular disease management in women.
  • Cardiomyopathies (dilated, arrhythmogenic, hypertrophic, restrictive) pose reproductive challenges, impacting contraception, pregnancy, and breastfeeding.
  • Limited guidance exists for balancing maternal safety and neonatal well-being in pregnant women with cardiomyopathy.

Purpose of the Study:

  • To provide a comprehensive overview of current evidence on reproductive counseling, pregnancy management, and postpartum care for women with cardiomyopathies.
  • To discuss cardiovascular risks, risk stratification, and therapeutic strategies for each cardiomyopathy subtype during pregnancy.
  • To address the safety and implications of breastfeeding in women with cardiomyopathy.

Main Methods:

  • Review of current evidence on reproductive counseling, pregnancy management, and postpartum care.
  • Discussion of cardiovascular risks associated with different cardiomyopathy subtypes during pregnancy.
  • Examination of risk stratification tools and emerging therapeutic strategies.

Main Results:

  • Cardiomyopathies present specific risks during pregnancy, necessitating careful management.
  • Breastfeeding safety and implications require specific consideration in postpartum care.
  • A multidisciplinary approach is crucial for optimizing maternal and fetal outcomes.

Conclusions:

  • Tailored patient counseling and management strategies are essential for safer reproductive choices in women with cardiomyopathy.
  • Bridging knowledge gaps and promoting personalized, evidence-based care are critical.
  • Multidisciplinary collaboration optimizes maternal and fetal outcomes in women with cardiomyopathy.

Related Concept Videos

Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
704
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
28
Birth Control Methods01:22

Birth Control Methods

Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
2.6K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
33
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
44